iANTHUS CAPITAL HOLDINGS (ITHUF) Depreciation & Amortization (CF) (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Depreciation & Amortization (CF) came in at $4.7 million in Q1 2026, down 0.74% year-on-year from $4.7 million in Q1 2025, and down 12.54% quarter-over-quarter from $5.3 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $4.7 million for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $4.7 million, down 0.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.3 million (down 16.55% YoY), and the FY2025 annual result was $19.3 million, down 22.02% from the prior year.
- Depreciation & Amortization (CF) came in at $4.7 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $5.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.0 million in Q1 2022 to a low of $132000.0 in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $6.1 million (2024), against an average of $5.4 million.
- Across the five-year window, Depreciation & Amortization (CF) tumbled 77.85% in 2022 and surged 4981.34% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Depreciation & Amortization (CF) stood at $6.6 million in 2022, then gained by 2.59% to $6.8 million in 2023, then fell by 10.75% to $6.0 million in 2024, then decreased by 11.6% to $5.3 million in 2025, then slipped by 12.54% to $4.7 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $4.7 million (Q1 2026), $5.3 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 4.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.67 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Jun 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 4.60 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Dec 31, 2023 | 6.77 Mn |